Floatz logo

Therapeutic Asset Ratings

236 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Lisinopril
Hepatocellular Carcinoma
Northwestern UniversityP2CCC (48)
Marijuana
Hepatocellular Carcinoma
University Medical Center GroningenP2CCC (48)
Memantine Hydrochloride
Hepatocellular Carcinoma
Inova Health Care ServicesP2CCC (48)
Pd-L1 T-Hank
Hepatocellular Carcinoma
ImmunityBio, Inc.P2CCC (48)
Pucotenlimab
Hepatocellular Carcinoma
Sun Yat-sen UniversityP2CCC (48)
Rosiglitazone
Hepatocellular Carcinoma
Dan ZandbergP2CCC (48)
rp2
Hepatocellular Carcinoma
Replimune, Inc.P2CCC (48)
SIMVASTATIN
Hepatocellular Carcinoma
National Cancer Institute (NCI)P2CCC (48)
Surufatinib
Hepatocellular Carcinoma
Zhongnan HospitalP2CCC (48)
Ucpvax
Hepatocellular Carcinoma
Centre Hospitalier Universitaire de BesanconP2CCC (48)
Ulixertinib
Hepatocellular Carcinoma
National Cancer Institute (NCI)P2CCC (48)
Vancomycin
Hepatocellular Carcinoma
Michael DillP2CCC (48)
vg161
Hepatocellular Carcinoma
Virogin Biotech Canada LtdP2CCC (48)
VIPIVOTIDE TETRAXETAN
Hepatocellular Carcinoma
Melissa LumishP2CCC (48)
Volrustomig
Hepatocellular Carcinoma
AstraZenecaP2CCC (48)
Zimberelimab
Hepatocellular Carcinoma
University of Texas Southwestern Medical CenterP2CCC (48)
GNS 561
Hepatocellular Carcinoma
Genoscience PharmaP1/2CC (45)
Polyiclc
Hepatocellular Carcinoma
Mayo ClinicP1/2CC (45)
Nelitolimod
Hepatocellular Carcinoma
University of California, San DiegoP1/2CC (44)
ipm001
Hepatocellular Carcinoma
Peking Union Medical College HospitalP1CC (42)
Γδ T Cells
Hepatocellular Carcinoma
Beijing 302 HospitalP1CC (42)
AK 127
Hepatocellular Carcinoma
AkesoP1/2CC (41)
ak130
Hepatocellular Carcinoma
AkesoP1/2CC (41)
Alintegimod
Hepatocellular Carcinoma
7 Hills Pharma, LLCP1/2CC (41)
Amsulostat
Hepatocellular Carcinoma
University of RochesterP1/2CC (41)
Showing 126 to 150 of 236 assets
PreviousPage 6 of 10Next